Published in Clin Infect Dis on June 01, 2008
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis (2011) 1.93
Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis (2009) 1.81
The Infectious Diseases Society of America emerging infections network: bridging the gap between clinical infectious diseases and public health. Clin Infect Dis (2014) 1.23
Preventing and treating biologic-associated opportunistic infections. Nat Rev Rheumatol (2009) 1.18
The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf (2010) 1.11
Tumor necrosis factor-alpha at the intersection of mycobacterial immunity and pathogenesis: an important new address in medicine. Clin Infect Dis (2008) 1.09
Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy. Nat Rev Rheumatol (2013) 1.01
Emerging trends in the formation and function of tuberculosis granulomas. Front Immunol (2013) 0.93
Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy. Intest Res (2014) 0.93
TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells. J Immunol (2008) 0.93
Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan. Mod Rheumatol (2011) 0.88
Application of a stochastic modeling to assess the evolution of tuberculous and non-tuberculous mycobacterial infection in patients treated with tumor necrosis factor inhibitors. PLoS One (2013) 0.86
Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis. Ann Rheum Dis (2015) 0.85
Mycobacterial infections in patients treated with tumor necrosis factor antagonists in South Korea. Lung (2013) 0.85
Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study. Ann Rheum Dis (2013) 0.84
Atypical mycobacterial infection presenting as persistent skin lesion in a patient with ulcerative colitis. Case Rep Med (2011) 0.84
[Recommendations for use of rituximab in patients with rheumatoid arthritis]. Z Rheumatol (2014) 0.82
Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review. Clin Rheumatol (2011) 0.82
Diagnosis and Treatment of Latent Tuberculosis Infection due to Initiation of Anti-TNF Therapy. Tuberc Respir Dis (Seoul) (2014) 0.81
Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in Taiwan. PLoS One (2016) 0.81
Infections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation. Front Oncol (2014) 0.81
Increased risk of revision for infection in rheumatoid arthritis patients with total hip replacements. Acta Orthop (2015) 0.77
Rationale of using different biological therapies in rheumatoid arthritis. Arthritis Res Ther (2010) 0.77
Pulmonary Mycobacterium kansasii Infection Mimicking Malignancy on the (18)F-FDG PET Scan in a Patient Receiving Etanercept: A Case Report and Literature Review. Case Rep Pulmonol (2014) 0.76
Rituximab for Rheumatoid Arthritis. Rheumatol Ther (2015) 0.75
Management of pulmonary nontuberculous mycobacterial disease. F1000 Med Rep (2009) 0.75
Pilot quasi-randomized controlled study of herbal medicine Hochuekkito as an adjunct to conventional treatment for progressed pulmonary Mycobacterium avium complex disease. PLoS One (2014) 0.75
Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium. Am J Trop Med Hyg (2015) 0.75
Mycobacterial disease attributable to tumor necrosis factor-alpha blockers. Clin Infect Dis (2008) 0.75
Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report. BMC Pulm Med (2015) 0.75
Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis. Rheum Dis Clin North Am (2018) 0.75
Risk of tuberculosis reactivation with rituximab therapy. Int J Health Sci (Qassim) (2017) 0.75
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun (1999) 14.25
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med (2002) 14.15
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol (2000) 9.85
Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation (2000) 6.96
Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation (2000) 5.36
Spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Nature (2001) 4.83
Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation (2001) 4.82
Abdominal fat: standardized technique for measurement at CT. Radiology (1999) 4.25
CD36 deficiency associated with insulin resistance. Lancet (2001) 3.82
Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med (1996) 3.02
An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res (2000) 2.59
IRE1 encodes a putative protein kinase containing a membrane-spanning domain and is required for inositol phototrophy in Saccharomyces cerevisiae. Mol Microbiol (1992) 2.38
Role of infectious diseases consultants in management of antimicrobial use in hospitals. Clin Infect Dis (2004) 2.35
Cloning and nucleotide sequence of the 2,3-dihydroxybiphenyl dioxygenase gene from the PCB-degrading strain of Pseudomonas paucimobilis Q1. Biochemistry (1988) 2.34
Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm. J Clin Microbiol (2002) 2.29
The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations. Clin Infect Dis (2004) 2.08
Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res (1994) 1.99
Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol (2003) 1.98
137Cs concentration among children in areas contaminated with radioactive fallout from the Chernobyl accident: Mogilev and Gomel oblasts, Belarus. Health Phys (1994) 1.93
JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway. Mol Cell Biol (1999) 1.90
The effect of spo0 mutations on the expression of spo0A- and spo0F-lacZ fusions. Mol Gen Genet (1986) 1.89
Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest (1995) 1.77
PCR amplification of rRNA intergenic spacer regions as a method for epidemiologic typing of Clostridium difficile. J Clin Microbiol (1995) 1.77
Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol (2000) 1.73
Yeast phosphatidylethanolamine methylation pathway. Cloning and characterization of two distinct methyltransferase genes. J Biol Chem (1987) 1.73
Nestin expression in the kidney with an obstructed ureter. Kidney Int (2007) 1.66
Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord (2000) 1.60
Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens. J Immunol (2001) 1.59
Radiocesium in children residing in the western districts of the Bryansk Oblast from 1991-1996. Health Phys (2000) 1.59
Drosophila 230-kD TFIID subunit, a functional homolog of the human cell cycle gene product, negatively regulates DNA binding of the TATA box-binding subunit of TFIID. Genes Dev (1993) 1.58
Multiple myeloma preceding the development of chronic myelogenous leukemia. Int J Hematol (1999) 1.57
An analysis of seasonality of sarcoidosis in the United States veteran population: 2000-2007. Sarcoidosis Vasc Diffuse Lung Dis (2012) 1.57
A national survey of severe influenza-associated complications among children and adults, 2003-2004. Clin Infect Dis (2005) 1.56
Zinn-Haller arterial ring observed by ICG angiography in high myopia. Br J Ophthalmol (1998) 1.56
Regulation of the phosphatidylethanolamine methylation pathway in Saccharomyces cerevisiae. Eur J Biochem (1982) 1.55
Depalmitoylation of endothelial nitric-oxide synthase by acyl-protein thioesterase 1 is potentiated by Ca(2+)-calmodulin. J Biol Chem (1999) 1.55
Prevalence of goiter and urinary iodine excretion levels in children around Chernobyl. J Clin Endocrinol Metab (1997) 1.52
Isolation and characterization of two distinct myo-inositol transporter genes of Saccharomyces cerevisiae. J Biol Chem (1991) 1.52
Glycerolipid acyltransferases from rat liver: 1-acylglycerophosphate acyltransferase, 1-acylglycerophosphorylcholine acyltransferase, and diacylglycerol acyltransferase. Methods Enzymol (1981) 1.52
Primary structure and disruption of the phosphatidylinositol synthase gene of Saccharomyces cerevisiae. J Biol Chem (1987) 1.49
Fish glucocorticoid receptor with splicing variants in the DNA binding domain. FEBS Lett (1996) 1.47
Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. J Pharmacol Exp Ther (1982) 1.47
Multiple sensitivity of chordat typani fibres of the rat and hamster to gustatory and thermal stimuli. J Physiol (1968) 1.47
National shortages of antimicrobial agents: results of 2 surveys from the Infectious Diseases Society of America Emerging Infections Network. Clin Infect Dis (2001) 1.44
Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis (2007) 1.43
Marked hypocholesterolemia in a case with adrenal adenoma--enhanced catabolism of low density lipoprotein (LDL) via the LDL receptors of tumor cells. J Clin Endocrinol Metab (1995) 1.43
Acceptable rates of treatment failure in osteomyelitis involving the diabetic foot: a survey of infectious diseases consultants. Clin Infect Dis (2004) 1.43
Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3. J Biol Chem (2000) 1.42
Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med (1997) 1.41
Thyroid cancer incidence in Ukraine: trends with reference to the Chernobyl accident. Radiat Environ Biophys (2010) 1.40
Fallout radioactivity in soil and food samples in the Ukraine: measurements of iodine, plutonium, cesium, and strontium isotopes. Health Phys (1994) 1.40
Gastrointestinal angiodysplasia in congenital platelet dysfunction. Int J Hematol (1996) 1.39
The Chernobyl accident and its consequences. Clin Oncol (R Coll Radiol) (2011) 1.38
CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol (1999) 1.38
Regulation of phosphatidylethanolamine methyltransferase level by myo-inositol in Saccaromyces cerevisiae. Eur J Biochem (1980) 1.37
Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism (1998) 1.33
Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen. J Immunol (2001) 1.32
Unique activity associated with non-insecticidal Bacillus thuringiensis parasporal inclusions: in vitro cell-killing action on human cancer cells. J Appl Microbiol (1999) 1.32
Rap2 as a slowly responding molecular switch in the Rap1 signaling cascade. Mol Cell Biol (2000) 1.32
Revised assignment for the Bacillus subtilis spo0F gene and its homology with spo0A and with two Escherichia coli genes. Nucleic Acids Res (1986) 1.30
Increased phospholipase D activity in human breast cancer. J Cancer Res Clin Oncol (1997) 1.30
Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J Clin Invest (1995) 1.28
Mutational analysis of familial and sporadic hyperekplexia. Ann Neurol (1995) 1.28
Aquaporin adipose, a putative glycerol channel in adipocytes. J Biol Chem (2000) 1.28
Interaction between the N-terminal domain of the 230-kDa subunit and the TATA box-binding subunit of TFIID negatively regulates TATA-box binding. Proc Natl Acad Sci U S A (1994) 1.27
Regulation of lipogenesis in animal tissues. Curr Top Cell Regul (1974) 1.27
Partial purification and properties of glycerophosphate acyltransferase from rat liver. Formation of 1-acylglycerol 3-phosphate from sn-glycerol 3-phosphate and palmityl coenzyme A. Eur J Biochem (1972) 1.26
Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol (1997) 1.25
A new formulation for orally disintegrating tablets using a suspension spray-coating method. Int J Pharm (2009) 1.24
Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects. J Lipid Res (2000) 1.23
Purification and characterization of phosphatidylcholine phospholipase D from pig lung. J Biol Chem (1994) 1.22
Zebrafish Dkk1 functions in forebrain specification and axial mesendoderm formation. Dev Biol (2000) 1.21
Identification of TFIID components required for transcriptional activation by upstream stimulatory factor. J Biol Chem (1993) 1.20
Management of inpatients colonized or infected with antimicrobial-resistant bacteria in hospitals in the United States. Infect Control Hosp Epidemiol (2005) 1.19
Posterior routes of choroidal blood outflow in high myopia. Retina (1996) 1.18
Cloning, expression, and characterization of a novel phospholipase D complementary DNA from rat brain. J Biol Chem (1997) 1.18
Cloning and characterization of the yeast CKI gene encoding choline kinase and its expression in Escherichia coli. J Biol Chem (1989) 1.18
15 years after Chernobyl: new evidence of thyroid cancer. Lancet (2001) 1.17
Molecular cloning and characterization of the gene encoding cholinephosphate cytidylyltransferase in Saccharomyces cerevisiae. Eur J Biochem (1987) 1.17
A gene that is related to SRY and is expressed in the testes encodes a leucine zipper-containing protein. Mol Cell Biol (1995) 1.16
Expression of copper trafficking genes in the mouse brain. Neuroreport (1998) 1.16
Thyroid dysfunction in patients with amyloid goitre. Clin Endocrinol (Oxf) (1997) 1.16
Parasporin, a human leukemic cell-recognizing parasporal protein of Bacillus thuringiensis. Clin Diagn Lab Immunol (2000) 1.15
Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis (1996) 1.14
Choline transport in Saccharomyces cerevisiae. J Bacteriol (1980) 1.14
Regulatory role of phosphatidate phosphatase in triacylglycerol synthesis of Saccharomyces cerevisiae. Biochim Biophys Acta (1984) 1.14
Partial purification, properties, and subcellulsr distribution of rat liver phosphatidate phosphatase. J Biochem (1975) 1.13
Essential contribution of germline-encoded lysine residues in Jgamma1.2 segment to the recognition of nonpeptide antigens by human gammadelta T cells. J Immunol (2001) 1.12
Proliferation of intrahyphal hyphae caused by disruption of csmA, which encodes a class V chitin synthase with a myosin motor-like domain in Aspergillus nidulans. J Bacteriol (1999) 1.12
CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem (1999) 1.12
Apoptosis of articular chondrocytes in rheumatoid arthritis and osteoarthritis: correlation of apoptosis with degree of cartilage destruction and expression of apoptosis-related proteins of p53 and c-myc. J Orthop Sci (2000) 1.12
Long exposure to high glucose concentration impairs the responsive expression of gamma-glutamylcysteine synthetase by interleukin-1beta and tumor necrosis factor-alpha in mouse endothelial cells. J Biol Chem (1996) 1.11
Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol (1995) 1.10
Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene (2011) 1.09
Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia--a possible pathogenesis of necrobiotic xanthogranuloma. Atherosclerosis (1999) 1.09
Identification of sna41 gene, which is the suppressor of nda4 mutation and is involved in DNA replication in Schizosaccharomyces pombe. Genes Cells (1998) 1.09
Computed tomography of malignant tumors of the nasal cavity and paranasal sinuses. Cancer (1982) 1.09
Visceral fat accumulation contributes to insulin resistance, small-sized low-density lipoprotein, and progression of coronary artery disease in middle-aged non-obese Japanese men. Jpn Circ J (2001) 1.08
Sensitive, direct colorimetric assay for copper in serum. Clin Chem (1989) 1.08